Wordt geladen...
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
BACKGROUND: Androgen receptor (AR) is widely expressed in breast cancer (BC) but its role in estrogen receptor (ER)-positive tumors is still controversial. The AR/ER ratio has been reported to impact prognosis and response to antiestrogen endocrine therapy (ET). METHODS: We assessed whether AR in pr...
Bewaard in:
| Gepubliceerd in: | BMC Cancer |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5872575/ https://ncbi.nlm.nih.gov/pubmed/29587674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4239-3 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|